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 Optic neuritis is an acute inflammatory 
demyelinating disorder of the optic nerve. The general 
characteristics of optic neuritis include unilateral, 
subacute, and painful visual loss without systemic or other 
neurological symptoms and optic neuritis is mostly seen in 
young females.1The etiology for optic neuritis varies 
including infections, inflammation, exposure to toxins, and 
genetic disorders. In most cases, the etiology may not be 
known for optic neuritis. In some cases, optic neuritis can 
be associated with demyelinating disorders of the central 
nervous system (CNS)including multiple sclerosis (MS) or 
neuromyelitis optic (NMO). Therefore, accurate diagnosis, 
risk assessment and management of patients with optic 
neuritis are warranted, and possibility of conversion to MS 
should be assessed [1,2] . 
Common characteristic symptoms of optic 
neuritis include visual problems, periorbital pain, and color 
vision deficits. Vision loss is usually unilateral and deficits 
can range in severity from mild (20/20) to severe (no light 
perception). Patients usually complain about periocular, 
retro-ocular pain prior to vision loss that commonly occurs 
with eye movements. Visual field defects are also common 
in acute demyelinating optic neuritis. Different visual field 
patterns are seen in optic neuritis and include diffuse visual 
field defects or focal defects with centrocecalscotoma 
being the most common visual field defect. The presence 
of afferent pupillary defect (APD) would suggest unilateral 
optic neuropathy. Vision defectsusually progress for the 
first 1–2 weeks and then visualrecovery usually begins 
within the first 4 weeks. Opticatrophy and disc pallor 
develops in 4–6 weeks [3,4]. Color vision is commonly 
affected and is evaluated by usingvarious color plates 
(Ishihara color plates, American Optical Hardy-Rand-
Rittler Color Vision Plates [HRR]).Optic neuritis is one of 
the most common initial clinical presentationsof MS 
without any prior history of a demyelinating event [1,4]. 
MSis an inflammatory autoimmune of the central 
nervous system that is characterized by pathologic 
changes, including demyelination and axonal 
injury.Magnetic Resonance Imaging (MRI) has become a 
routine clinical examination in MS. MRI is the most 
important paraclinical tool for MS, and derived measures 
have been established as standard outcome markers to 
monitor the treatment response in various MS clinical trials 
[5]. 
MRI findings seem to predict strongly the risk of 
developing MS. Studies have shown that spinal cord 
lesions might be strong indicators for predicting MS risk. 
Usually the involved optic nerve would be hyperintense 
with contrast enhancement. If there are brain and spinal 
cord lesions compatible with MS, the characteristics of the 
demyelinating lesions would include 3 mm ovoid lesions 
that are mostly located in periventricular areas of the white 
matter and radiate toward the ventricular spaces. The 
chance of developing MS increases for patients with one or 
more lesions. In recent practice, McDonald’s criteria are 
the most utilized diagnostic criteria to assess the MS 
conversion risk in patients with a single demyelinating 
episode by providing MRI evidence for dissemination in 
space (DIS) and dissemination in time (DIT). While 
evaluating patients with a first episode of optic neuritis, in 
addition to MRI, additional tests including cerebrospinal 
fluid (CSF) analysis, evoked potentials (visual, motor, 
somatosensory, brain auditory) might also be helpful. 
Visual Evoked Potentials (VEPs) reflect demyelination in 
the afferent visual pathways. VEPs seem to be sensitive 
and specific for detecting optic neuritis with no apparent 
clinical presentation and abnormal findings even in silent 
cases.Abnormal VEP findings include increased latencies 
and reduced amplitudes and abnormal waveforms [6,7].  
Corticosteroids have been recommended for 
treating acute optic neuritis. There is still no consensus 
about the application of corticosteroid (intravenous or oral 
forms), dosage, and treatment duration. Often, clinical 
presentation of optic neuritis is the main factor for the 
decision maker for initiating and duration of acute therapy. 
Management of optic neuritis could be with oral 
prednisone (1 mg/kg/d for 14 days) or intravenous 
methylprednisolone (250 mg every 6 hours for 3 days) 
followed by an oral prednisone taper (1 mg/kg/d for 11 
days). The recommendation of Optic Neuritis Treatment 
Trial (ONTT) is to treat acute optic neuritis with iv high 
dose corticosteroid [8,9].  
 
Case report 
 A 5 years old girl suddenly blurred vision in both 
eyes and headache within 4 days before admitted in 
outpatient clinic. Patient had no fever and neurologic 
deficit. Visual acuity in first day were hand movement, 
color vision difficult to be evaluated in both eyes and right 
eye positive relative afferent pupillary defect. Posterior 
segment evaluation from fundus photograph showed 
bilateral edema optic nerve (Figure 1).  
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Figure 1. Fundus photograph before intravenous methylprednisolone. Both eyes showed optic disc edema 
 
MRI showed bilateral optic neuritis, chronic 
plaque in right parietal lobe, right and left centrum 
semiovale (Figure 2). VEP showed demyelinating lesion in 
bilateral visual pathway.  
 
 
Figure 2. MRI showed bilateral optic neuritis, chronic plaque in right parietal lobe, right and left centrum semiovale 
according to multiple sclerosis.  
 
The patient was diagnosed with bilateral optic 
neuritis associated multiple sclerosis and hospitalized with 
treatment of intravenous methylprednisolone 500 mg 
divided 4 times a day and continued with oral prednisone 
start on the sixth days. After treatment with intravenous 
corticosteroid until fifth days follow up, BCVA and color 
vision improve gradually. At fifth day, the visual acuity on 
right eye was 3/60 and left eye 1/60 with presence of APD. 
Funduscopy on both eye were improved with optic nerve 
head sharp margin but still hyperemia condition (Figure 3).  
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Figure 3.Fundus photograph after intravenous methylprednisolone on 5th days follow up 
 
At sixth day follow up showed the improvement 
of visual acuity with 5/60 on the right eye and 1/60 on the 
left eye. At the ninth day follow up, the visual acuity 
significantly improved become 5/5 on right eye and 5/8.5 
on left eye. It had show that corticosteroid became 
successful therapy for this patient. Fundus photograph both 
eyes at ninth days follow up after oral prednisone therapy 
showed a disc edema subsided (Figure 4). A month follow 
up, BCVA on right and left eye were 5/5 and Ishihara test 
on both eyes were 14/14. Fundus photograph showed 
normal optic nerve head (Figure 5).  
 
 
Figure 4. At 9th days follow up. Fundus photograph after 3 days of oral prednisone treatment 
 
Figure 5. Fundus photograph after oral prednisone treatment on a month follow up. It showed a normal fundus 
Discussion  
 
Optic neuritis is an acute inflammatory disorder 
of the optic nerve, typically presents with sudden 
monocular visual loss and eye pain in young adults, 
without systemic or other neurological symptoms and also 
more commonly in women. It is a common initial 
manifestation of multiple sclerosis (MS) [10,11]. In this 
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case, patient suddenly blurred vision in both eyes and got 
headache but patient had no fever and neurologic deficit 
[10].  
In most cases, the etiology may not be known for 
optic neuritis that can be associated with multiple sclerosis 
(MS). A relationship between optic neuritis and MS has 
been well recognized for many years. The risk was strongly 
related to MRI evidence of prior demyelination in the white 
matter ofthe brain at the time of optic neuritis onset. 
Multiple sclerosis (MS) is an inflammatory 
autoimmune of the central nervous system  
that is characterized by pathologic changes, including 
demyelination and axonal injury. MR imaging is the most 
important paraclinical tool for MS. Magnetic Resonance 
Imaging (MRI) findings seem to predict strongly the risk 
of developing MS. The characteristics of the demyelinating 
lesions would include 3 mm ovoid lesions that are mostly 
located in periventricular areas of the white matter and 
radiate toward the ventricular spaces [5].  
In this case, MRI showed bilateral optic neuritis, 
chronic plaque in right parietal lobe, right and left centrum 
semiovale. When at least one lesion was present, the risk 
was fairly consistent throughout the 15 years and did not 
substantially increase when additional lesions were 
present. Regardless of whether brain MRI lesions were 
present at the time of optic neuritis, neurologic disability 
was mild in most patients who developed MS [1].  
Vision loss is usually unilateral and deficits can 
range in severity from mild (20/20) to severe (no light 
perception). Vision defects usually progress for the first 1–
2 weeks and then visual recovery usually begins within the 
first 4 weeks. From patient condition, the visual acuity on 
both eyes were a hand movement that showed severe vision 
loss, but after follow up until 9th days, had showed 
significantly improvement of visual acuity. At a month 
follow up, this patient had no complained about blurred 
vision. From the visual acuity examination on both eye 
showed normally with normal fundus from fundus 
photograph. 
VEPs seem to be sensitive and specific for 
detecting optic neuritis even in silent cases with no 
apparent clinical presentation and abnormal findings are 
often observed in silent cases. Abnormal VEP findings 
include increased latencies and reduced amplitudes and 
abnormal waveforms. In this case, VEP showed 
demyelinating lesion in bilateral visual pathway [1,7].  
Management of optic neuritis could be with oral 
prednisone (1 mg/kg/d for 14 days) or intravenous 
methylprednisolone (250 mg every 6 hours for 3 days) 
followed by an oral prednisone taper (1 mg/kg/d for 11 
days). The recommendation of ONTT is to treat acute optic 
neuritis with intravenous high dose corticosteroid. Other 
study showed that a 3-day course of methylprednisolone 
given intravenously in a dose of 250 mg every 6 hours 
followed by 2 weeks of daily oral prednisone in a dose of 
1 mg/kg/day accelerated visual recovery but did not 
improve the eventual visual outcome.In this patient 
condition, initial treatment with intravenous 
methylprednisolone 500 mg divided 4 times daily for 5 
days then followed by prednisone 1 mg/kg/day for 2 weeks. 
The result was patient had better visual outcome and had 
significantly improvement of visual acuity and fundus 
photograph [1,3].  
 
Conclusion 
 Optic neuritis can be associated withmultiple 
sclerosis. Eye examination include BCVA, color vision 
test, fundus photograph, and radiology imaging with MRI, 
also additional test include visual evoked potential might 
be helpful to diagnosis optic neuritis associated multiple 
sclerosis. Management therapy of optic neuritis with high 
dose corticosteroid followed by oral prednisone give better 
visual outcome. 
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Introduction :Optic neuritis can be associated with 
multiple sclerosis (MS). Therefore, accurate diagnosis, 
risk assessment and management of patients with optic 
neuritis associated multiple sclerosis should be assessed.  
Method: A 5 years old girl suddenly blurred vision in 
both eyes and headache within 4 days before admitted in 
outpatient clinic. Patient had no fever and neurologic 
deficit. Visual acuity in first day were hand movement, 
color vision difficult to be evaluated in both eyes and 
right eye positive relative afferent pupillary defect. 
Posterior segment evaluation showed bilateral edema 
optic nerve. MRI showed bilateral optic neuritis, chronic 
plaque in right parietal lobe, right and left centrum 
semiovale. VEP showed demyelinating lesion in bilateral 
visual pathway. Patient was given intravenous 
methylprednisolone 500 mg divided 4 times a day and 
continued with oral prednisone start on the sixth days. 
Result: After treatment with intravenous corticosteroid 
until fifth days follow up, BCVA and color vision 
improve gradually. At the ninth days follow up, BCVA on 
right eye (RE) 5/5 and left eye (LE) 5/8.5 pinhole not 
improve. Ishihara on RE 12/14 and LE 10/14. 
Ophthalmoscopy examination showed disc edema 
subsided in the follow up. A month follow up, BCVA and 
Ishihara on both eye were5/5 and 14/14. Opthalmoscopy 
examination showed normal optic nerve head. 
Conclusion: Bilateral optic neuritis in a child associated 
multiple sclerosis is a challenging case. Intravenous 
methylprednisolone is the first line drug therapy give 
better visual outcome.  
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